𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of a Sulfobutyl Ether β-Cyclodextrin as a Solubilizing/Stabilizing Agent for Several Drugs

✍ Scribed by Ueda, H.; Ou, D.; Endo, T.; Nagase, H.; Tomono, K.; Nagai, T.

Book ID
120761946
Publisher
Informa plc
Year
1998
Tongue
English
Weight
319 KB
Volume
24
Category
Article
ISSN
0363-9045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Sulfobutyl Ether β-Cyclodextrin a
Use of Sulfobutyl Ether β-Cyclodextrin as a Vehicle for d-threo-1-Phenyl-2-decanoylamino-3-morpholinopropanol-Related Glucosylceramide Synthase Inhibitors
✍ Akira Abe; Susan Gregory; Lihsueh Lee; James A. Shayman 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 62 KB

D-threo-1-Phenyl-2-decanoylamino-3-morpholinopropanol (PDMP) 2 is a prototypic glucosylceramide synthase inhibitor first described by Vunnam and Radin (1). Subsequently, a series of PDMP homologues based

Controlled porosity-osmotic pump pellets
Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-β-cyclodextrin, (SBE)7M-β-CD, as a solubilizing and osmotic agent
✍ Sutthilug Sotthivirat; John L. Haslam; Valentino J. Stella 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

The objective of this work was to demonstrate that the incorporation of sulfobutylether-beta-cyclodextrin, (SBE)(7M)-beta-CD, results in the complete and sustained release of a sparingly water-soluble drug, prednisolone (PDL) from controlled porosity-osmotic pump pellets (CP-OPP). PDL and CD were pr

Controlled and complete release of a mod
Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)7m-β-cyclodextrin as a solubilizing agent
✍ Venkatramana M. Rao; John L. Haslam; Valentino J. Stella 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

Sustained-release formulations such as hydroxypropyl methylcellulose (HPMC)based hydrophilic matrix tablets of poorly water-soluble drugs often result in incomplete release because of the poor solubility and dissolution rate of the drug in the hydrophilic matrix. Sulfobutylether-b-cyclodextrins ((SB

Design of tablets for the delayed and co
Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent
✍ Venkatramana M. Rao; Erika A. Zannou; Valentino J. Stella 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

The challenge of designing a delayed-release oral dosage form is significantly increased when the drug substance is poorly water soluble. This manuscript describes the design and characterization of a novel controlled-release film-coated tablet for the pH-triggered delayed and complete release of po